E-DRUG Archives (by date)

• Thread Index

October 31, 2004
• [e-drug] rofecoxib ban in India (5)
  • From: "Kibumba George" <kibumba@yahoo.com>
October 30, 2004
• [e-drug] Cost of Viral Load Test down by 60%
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Evidence based medicine for developing countries
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Fair Access to Clinical Trials Act
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] occupational risks of antineoplastic API production? (2)
  • From: "Rakesh Chaurasia" <chaurasiarakesh@macleodspharma.com>
October 29, 2004
• [e-drug] RFI: quinine syrup (3)
  • From: "David Woods" <david.woods@stonebow.otago.ac.nz>
• [e-drug] USA pays high prices for global AIDS drugs
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Masters thesis on paediatric formulations (2)
  • From: "Satu Siiskonen" <satu@fip.org>
• [e-drug] RFI: quinine syrup (2)
  • From: "O. M. S. Minzi" <ominzi@muchs.ac.tz>
October 28, 2004
• [e-drug] Pharmacy Education Symposium, Italy 2005
  • From: "Rohan Elliott" <Rohan.ELLIOTT@austin.org.au>
• [e-drug] occupational risks of antineoplastic API production?
  • From: "Sunil Singh" <sunils@drreddys.com>
• [e-drug] Cost of retaining essential staff?
  • From: "Bonface Fundafunda" <bcfunda@hotmail.com>
• [e-drug] Malaria News: resistance, counterfeits
  • From: "Leela McCullough" <leela@healthnet.org>
• [e-drug] The World's First TB Vaccine in Eighty Years
  • From: "Leela McCullough" <leela@healthnet.org>
• [e-drug] Masters thesis on paediatric formulations
  • From: "Lombe Kasonde" <lkasonde@unicef.org>
• [e-drug] 34rd edition of Martindale (5)
  • From: "Eurek Ranjit" <dhyan@wlink.com.np>
• [e-drug] RFI: quinine syrup
  • From: "Betty Njau" <mriab76@yahoo.com>
• [e-drug] Martindale Online Access
  • From: "JPS Kohli" <info@businesshorizons.com>
• [e-drug] 34th edition of Martindale (4)
  • From: "Murtada Sesay" <msesay@unicef.org>
• [e-drug] 34rd edition of Martindale (3)
  • From: "Serutoke, Mr. Joseph - ug" <Serutokej@ug.afro.who.int>
• [e-drug] Cost/efficient procurement
  • From: "Arnaud PECOURT" <arnaud.pecourt@wanadoo.fr>
• [e-drug] Australian Endocrinology Guidelines
  • From: "Enid Meldrum" <emeldrum@tg.com.au>
• [e-drug] 34rd edition of Martindale (2)
  • From: "Moses Mwaniki" <MosesN@psikenya.org>
• [e-drug] Can we document experiences with PEPFAR please? (7)
  • From: B.Futter@ru.ac.za
• [e-drug] MSF: TB is spiralling out of control (2)
  • From: "Wasonga, John (KENYA/OPH)" <JWasonga@usaid.gov>
October 27, 2004
• [e-drug] Can we document experiences with PEPFAR please? (6)
  • From: "Sharonann Lynch" <salynch@healthgap.org>
• [e-drug] Can we document experiences with PEPFAR please? (5)
  • From: "Essential Drugs Project" <edp@gn.apc.org>
• [e-drug] 34rd edition of Martindale
  • From: "E-Drug" <e-drug@healthnet.org>
October 26, 2004
• [e-drug] MSF: TB is spiralling out of control
  • From: "Sean Healy" <Sean.HEALY@geneva.msf.org>
October 25, 2004
• [e-drug] Need for a protocol repository
  • From: "Kent Johnson" <Kent.Johnson@newcastle.edu.au>
• [e-drug] Drugs companies are defrauding healthcare systems? (2)
  • From: "Roger Klotz" <RKlotz@SPCLIN.com>
• [e-drug] Ethics of clinical trials in developing countries (3)
  • From: "J. Philip Miller" <jphilipmiller@wustl.edu>
• [e-drug] Essential drugs without essential staff (5)
  • From: B.Futter@ru.ac.za
• [e-drug] proposed WHO EML changes 2005
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Ethics of clinical trials in developing countries (2)
  • From: "Wendy L Armstrong" <wlarmstr@telusplanet.net>
• [e-drug] brand vs generic simvastatin prices? (2)
  • From: "hans platteeuw" <hansplatteeuw@yahoo.com>
October 24, 2004
• [e-drug] Before or after food? (2)
  • From: "Elizabeth Ominde-Ogaja" <lizogaja@wananchi.com>
• [e-drug] Ethics of clinical trials in developing countries
  • From: "Beverley Snell" <bev@burnet.edu.au>
• [e-drug] rofecoxib ban in India (4)
  • From: "Eurek Ranjit" <dhyan@wlink.com.np>
• [e-drug] RFI: clinical trials in India
  • From: "Mark Nichter" <Mnichter@u.arizona.edu>
• [e-drug] rofecoxib ban in India (3)
  • From: "Raj" <pharmhin@sancharnet.in>
• [e-drug] Essential drugs without essential staff (4)
  • From: "Timothy Mahlatsi" <MahlatsiGT@TUT.AC.ZA>
• [e-drug] brand vs generic simvastatin prices?
  • From: valeria.frighi@doctors.org.uk
• [e-drug] rofecoxib ban in India (2)
  • From: "sdrajendran" <sdrajendran@hotmail.com>
• [e-drug] drug companies and regulators in the spotlight
  • From: "E-Drug" <e-drug@healthnet.org>
October 23, 2004
• [e-drug] rofecoxib ban in India
  • From: "clinicsindia" <clinicsindia@vsnl.net>
October 22, 2004
• [e-drug] Essential drugs without essential staff? (3)
  • From: "Kibumba George" <kibumba@yahoo.com>
• [e-drug] Drugs companies are defrauding healthcare systems?
  • From: "Klara Tisocki" <ktisocki@yahoo.ie>
• [e-drug] Indian drug R&D has bright future
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] APPROVe (VIOXX) trial publication? (2)
  • From: "Chandra Gulhati" <seeemgee@yahoo.co.uk>
• [e-drug] APPROVe (VIOXX) trial publication?
  • From: "Ruwan Prasad" <ruwanprsd@yahoo.com>
October 21, 2004
• [e-drug] Pharmaceutical Commodities Management Officer
  • From: "Jacqui Patterson" <jacquipatterson@interchurch.org>
• [e-drug] Can we document experiences with PEPFAR please? (4)
  • From: "Elizabeth Gardiner" <egardiner.sln2003@london.edu>
• [e-drug] Essential drugs without essential staff? (2)
  • From: "Emeje Martins" <martinsemeje@yahoo.com>
• [e-drug] Two drug systems in the U.S. (10)
  • From: "Sarah Sellers" <ssellers@jhsph.edu>
• [e-drug] Essential drugs without essential staff?
  • From: "Billy Futter" <B.Futter@ru.ac.za>
October 20, 2004
• [e-drug] Two drug systems in the U.S. (9)
  • From: "Stevan Gressitt" <gressitt@uninets.net>
• [e-drug] Defense Contractors Seek $7-Billion Drug Grant
  • From: "Johanna Crane" <jcrane@itsa.ucsf.edu>
• [e-drug] Two drug systems in the U.S. (8)
  • From: "Kazeem Babatunde" <yusuffkby@yahoo.co.uk>
• [e-drug] Two drug systems in the U.S. (7)
  • From: "Parrish Richard" <RParrish@su.edu>
• [e-drug] Electronic Listing of Registered Products? (2)
  • From: "Natalie Pieterse" <Natalie@biotech.co.za>
• [e-drug] Electronic Listing of Registered Products?
  • From: "Murtada Sesay" <msesay@unicef.org>
• [e-drug] Two drug systems in the U.S. (6)
  • From: "Dr.L.Offerhaus" <offerhausl@euronet.nl>
• [e-drug] vioxx withdrawal - insider story
  • From: "E-Drug" <e-drug@healthnet.org>
October 19, 2004
• [e-drug] Two drug systems in the U.S. (5)
  • From: "Sarah Sellers" <ssellers@jhsph.edu>
• [e-drug] Two drug systems in the U.S. (4)
  • From: "Parrish Richard" <RParrish@su.edu>
• [e-drug] Two drug systems in the U.S. (3)
  • From: "Sarah Sellers" <ssellers@jhsph.edu>
• [e-drug] Can we document experiences with PEPFAR please? (3)
  • From: "Francisco Rossi" <francisco_rossi@hotmail.com>
• [e-drug] Let the Pharmaceutical Industry Speak (3)
  • From: "Wasonga, John (KENYA/OPH)" <JWasonga@usaid.gov>
• [e-drug] Can we document experiences with PEPFAR please? (2)
  • From: "KAZEEM BABATUNDE" <yusuffkby@yahoo.co.uk>
• [e-drug] Two drug systems in the U.S. (2)
  • From: "KAZEEM BABATUNDE" <yusuffkby@yahoo.co.uk>
October 18, 2004
• [e-drug] after Vioxx, now Bextra? (2)
  • From: "Roger Klotz" <RKlotz@SPCLIN.com>
• [e-drug] Two drug systems in the U.S.
  • From: "Sarah Sellers" <ssellers@jhsph.edu>
• [e-drug] after Vioxx, now Bextra?
  • From: "E-drug" <e-drug@healthnet.org>
• [e-drug] Can we document experiences with PEPFAR please?
  • From: "EPN Nairobi" <epn@wananchi.com>
• [e-drug] Rational Drug Management Course
  • From: natascha_petersen@urz.uni-heidelberg.de
October 17, 2004
• [e-drug] a malaria vaccine by 2010? (2)
  • From: "Bernhard Edgren" <be@triuno.com>
• [e-drug] Access to Medicines in Under-served Markets: overview (2)
  • From: "Richard T. Mahoney" <richard.mahoney@asu.edu>
October 16, 2004
• [e-drug] Antidepressants in USA to carry warning for young
  • From: "Libby Levison" <libby@theplateau.com>
• [e-drug] a malaria vaccine by 2010?
  • From: "Libby Levison" <libby@theplateau.com>
• [e-drug] Comments about PEPFAR (2)
  • From: "Libby Levison" <libby@theplateau.com>
• [e-drug] Strong medicine - Incentives for R&D on Neglected Diseases
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] WHO Essential Medicines List 2005: deadline 31 Oct
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Drug maker promotes generics for its own workers
  • From: "Joana Ramos" <joaninha@comcast.net>
October 14, 2004
• [e-drug] vacancy: IDA South Africa project manager
  • From: "Mrs Marieke Dekker" <mdekker@ida.nl>
• [e-drug] ATM: willingness and ability to utilise TRIPS flexibilities
  • From: "E-Drug" <e-drug@healthnet.org>
October 13, 2004
• [e-drug] Access to Medicines in Under-served Markets: overview
  • From: "E-drug" <e-drug@healthnet.org>
• [e-drug] Access to Medicines and Intellectual Property Rights
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
October 12, 2004
• [e-drug] bad bugs, no drugs
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Avian influenza should be ruffling our feathers
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Let Pharmaceutical Companies Speak (2)
  • From: "Kibumba George" <kibumba@yahoo.com>
• [e-drug] Alternatives for the patent system? (3)
  • From: "Parrish Richard" <RParrish@su.edu>
• [e-drug] E-DRUG: The Truth About the Drug Companies (5)
  • From: "JPS Kohli" <info@businesshorizons.com>
• [e-drug] The Truth About the Drug Companies (4)
  • From: "E-drug" <e-drug@healthnet.org>
• [e-drug] Financing drug research and development (2)
  • From: "Dr.L.Offerhaus" <offerhausl@euronet.nl>
October 11, 2004
• [e-drug] Financing drug research and development
  • From: "Marcus Reidenberg" <mmreid@med.cornell.edu>
• [e-drug] Essential drugs for mental health
  • From: "Kees de Joncheere" <cjo@euro.who.int>
• [e-drug] Corporate sponsorship of diabetes campaigns in developing countries
  • From: "Patient View" <info@patient-view.com>
• [e-drug] For a Balanced Debate, Let the Pharmaceutical Industry Speak (2)
  • From: "jude ike nwokike" <monkiyke@yahoo.com>
• [e-drug] Pharmaceutical Companies might not be making a lot (2)
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] The Truth About the Drug Companies (3)
  • From: "Dr S Toovey" <toovey@travelclinic.co.za>
• [e-drug] Allergy to latex condoms?
  • From: "psupc" <psupc@infocom.co.ug>
October 10, 2004
• [e-drug] Pharmaceutical Companies might not be making a lot
  • From: "Kibumba George" <kibumba@yahoo.com>
October 09, 2004
• [e-drug] For a Balanced Debate, Let the Pharmaceutical Industry Speak
  • From: "Kibumba George" <kibumba@yahoo.com>
October 08, 2004
• [e-drug] The Truth About the Drug Companies (2)
  • From: "Dr Valeria Frighi" <valeria.frighi@doctors.org.uk>
• [e-drug] Alternatives for the patent system? (2)
  • From: "Dr.L.Offerhaus" <offerhausl@euronet.nl>
• [e-drug] The Truth About the Drug Companies
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Alternatives for the patent system?
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] The World Medicines Situation
  • From: "E-drug" <e-drug@healthnet.org>
• [e-drug] Vioxx - another block buster goes bust
  • From: "Ayyaz Kiani" <ayyaz_kiani@hotmail.com>
October 07, 2004
• [e-drug] fake artemisinins and ARVs in DR Congo (3)
  • From: "Sabine Kopp" <kopps@who.int>
October 06, 2004
• [e-drug] donor required for second line TB drugs in Nepal
  • From: "Drug Information Center, Manipal Teaching Hospital, Pokhara" <dicmth@fewanet.com.np>
• [e-drug] USAID Awards TB Alliance $8 Million Grant
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] The need for openness in drug regulation
  • From: "E-drug" <e-drug@healthnet.org>
October 05, 2004
• [e-drug] Workshop on TB Pharmaceutical Management: 29 October, Paris
  • From: "Beith,Alix" <abeith@msh.org>
• [e-drug] BBC Panorama on antidepressants and UK Regulatory Authority (2)
  • From: "Dr.L.Offerhaus" <offerhausl@euronet.nl>
• [e-drug] urgent clinical advice needed
  • From: "Drug Information Center, Manipal Teaching Hospital, Pokhara" <dicmth@fewanet.com.np>
October 04, 2004
• [e-drug] Australian Prescriber October issue
  • From: "Susan Reid" <sreid@nps.org.au>
• [e-drug] FIP launches International Network for Pharmacists on HIV/AIDS
  • From: "Teresa Alves" <teresa@fip.org>
• [e-drug] BBC Panorama examines antidepressants and UK Regulatory Authority
  • From: "E-Drug" <e-drug@healthnet.org>
October 03, 2004
• [e-drug] Is that it, then, for blockbuster drugs?
  • From: "E-Drug" <e-drug@healthnet.org>
October 02, 2004
• [e-drug] ICIUM 2004 recommendations and presentations online
  • From: "E-drug" <e-drug@healthnet.org>
October 01, 2004
• [e-drug] Vioxx withdrawal (2)
  • From: "Peter R Mansfield" <peter@healthyskepticism.org>
• [e-drug] What is the pharmaceutical industry up to?
  • From: "E-drug" <e-drug@healthnet.org>
September 30, 2004
• [e-drug] Book: Managing Pharmaceuticals in International Health
  • From: "reinhard huss" <reinhard.huss@urz.uni-heidelberg.de>